Dr. John Tsai grabbed the reins of global R&D this year with a clear mandate: extend Daiichi’s oncology momentum beyond its ...

The error points to a big question for pharma as AI gains autonomy and high-profile failures sharpen safety concerns: What ...

The Danish biotech sharpened its global vaccine ambitions by tapping Tarja Stenvall, a Big Pharma vet, to take the helm.

Nimbus Therapeutics’ head of R&D dishes on what’s next in AI-enabled drug discovery, years after Takeda completed its ...

Roche announced it's building autonomous AI-powered labs; how a clinical hold on an epilepsy trial could impact Biohaven ...

Companies including GSK, Merck, Roche and Sanofi are pushing new approaches in cancer and inflammatory diseases.

Basecamp Research just netted $140 million in a series C fundraising round that valued the company at $800 million, according ...

Patients in psychedelic trials often know if they’re taking the study drug or a placebo. But trial design changes could ...

Genetic medicines and more selective small molecules are finally pushing the field toward new mechanisms — and potentially ...

President Donald Trump’s various most-favored nation deals with pharma companies are purportedly intended to lower prices and slash federal drug spending. But the agreements could get in the way of ...